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Introduction
Although findings of previous studies on stem cell therapy in chronic heart failure were ambiguous, beneficial effects on cardiac function have been described for distinct types of therapy (Sanganalmath and Bolli 2013) . Intracoronary, intramyocardial and retrograde stem cell transplantation has been applied; however, the optimal approach remained still unknown, and use of the pericardial sac has not been sufficiently explored in this regard. The pericardium is known as appropriate target of antiinflammatory drug delivery, e.g. for treatment of pericarditis (Adler et al. 2015; Alter et al. 2013; Glück et al. 2016; Maisch and Pankuweit 2012) . In addition, it is known that drugs applied into the pericardial space can penetrate the myocardium (Marcano et al. 2013 ). There are yet only very few studies on myocardial homing of stem cells after intrapericardial administration (Blázquez et al. 2015; Blázquez et al. 2016; Branco et al. 2009 ). None of them considered amplifying effects of local inflammation.
Mesenchymal stem cells exhibit a self-renewal capacity and bear the potential of multiple ways of further differentiation (Pittenger et al. 2000) . Multipotent cells can be isolated from bone marrow (Zhang and Chan 2010) .
Material and methods
The present study examines influences of inflammation on myocardial stem cell homing after injection of allogene mesenchymal stem cell (MSC) into the pericardial space of 10 Wistar WU rats. In 5 of these experimental animals, a sterile pericarditis was induced by talc. In addition, in 5 animals the surgical intervention was used as sham procedure without stem cell application (Figure 1 ). All experimental protocols were approved by the local ethics committee. D r a f t 4 / 10 For stem cell extraction, male rats were euthanized and bone marrow aspirate was isolated. Cell suspension was washed and expanded using DMEM (Dulbecco's Modified Eagle's Medium) containing 10 % fetal bovine serum (FBS), penicillin and streptomycin. Non-adherent hematopoietic cells were removed. To show the multipotent nature of these MSC, standard protocols were used to induce adipogenic (Choi et al. 2008 ) and osteogenic (Salasznyk et al. 2004) These Rats were anesthetized with isoflurane and ventilated by endotracheal intubation. The pericardial space was accessed by right-sided thoracotomy. Full doses of 1*10 6 PKH-26 labeled MSC were injected into pericardial space in 10 acceptor rats.
In a subgroup of 5 animals, sterile pericarditis was induced by 30µg/kg talc. A balanced electrolyte solution was used for controls (n = 5). Two days after mesenchymal stem cell administration acceptor rats were euthanized, histological examination was performed using frozen slices and the number of detected cells was extrapolated to the complete cardiac mass as measured (Rupp et al. 2010 
Results
No experimental or periprocedural deaths occurred and no significant differences between pre-and postprocedural body weight were observed among the groups D r a f t 5 / 10 (Table 1 ). In animals with sterile pericarditis, a thickened pericardial layer was identified. The pericardial mass normalized to total body weight (BW) was significantly increased in pericarditis when compared with non-pericarditis or controls (p < 0.05), while stem cell application without pericarditis resulted not in an increase of pericardial mass (Table 1) . Previous data showed that talc alone lead to a similar increase of pericardial mass (König 2002) . No significant differences of myocardial weight normalized to total body mass were observed among the groups.
Myocardial homing of stem cells was shown by microscopic evaluation of PKH-26 labeled cells (Figure 2 ). No specific fluorescence was observed in controls.
Histological analysis showed no evidence of a specific homing pattern. Myocardial homing was indicated by a significant increase of stem cells when compared with controls (p < 0.05). Of note, the extent of homing was significantly increased in pericarditis when compared with non-pericarditis and controls (p < 0.05, Figure 2 ).
Discussion
In the present study, it was shown that stem cells applied into the pericardial space penetrate the epicardial border into the myocardium. To our best knowledge, this is the first study reporting effects of inflammation in terms of a sterile pericarditis on increased myocardial homing. MSC viability, the proliferative behavior and phenotypic pattern appears unaffected by exposure to pericardial fluid as previously shown (Blázquez et al. 2015) . Pericardial fluid with a low turnover rate has the potential to serve as therapeutic depot, which allows delivery of high doses of MSC into pericardial sac.
It is a limitation of the present study that invasion of sex mismatched cells was not confirmed by a second method, e.g. real-time quantitative PCR (qPCR) or fluorescence in situ hybridization (FISH). However, the feasibility of the concept is in line with other recent studies, in which myocardial homing of intrapericardially applied stem cells was shown (Blázquez et al. 2015; Blázquez et al. 2016; Branco et al. 2009 ).
Further studies are required to investigate the detailed pathway of stem cell homing;
there is evidence that inflammation could be play an essential role (Zhang et al. 2016 ).
Potential prognostic benefits of this method of stem cell application need to be addressed in future studies.
Conclusions
In contrast to previous methods of application, a pericardial approach bears several potential advantages: First, pericardial fluid has contact to large epi-/myocardial areas, which could be helpful for treatment of diffuse myocardial diseases, e.g.
cardiomyopathies. Thus, the targeted area of myocardium is beyond the proportion as addressed by local intracoronary application. Second, the pericardial sac serves as depot and thus provides longer penetration times when compared with an intracoronary injection. Noteworthy, inflammation appears to increase the extent of stem cell penetration to the myocardium. Third, microvascular obstruction, as frequently observed in acute coronary syndrome, impedes the vascular flow and thus an intracoronary stem cell delivery into the area of ischemia. In turn, stem cell application itself is expected to lead to microvascular obstruction.
In sum, the pericardial approach appears a favorable technique that should be envisaged for stem cell application in heart failure. The clinical feasibility and potential benefits remain to be shown in further studies. 
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